Warning letterFDA · Nov 22, 2022
Aspire Pharmaceuticals, Inc. MARCS-CMS 630328, November 22, 2022
Named company: Aspire Pharmaceuticals, Inc.
Based on our inspection and our. review of labeling collected during the inspection, we identified significant violations of the Federal Food, Drug, and Cosmetic Act (the Act). We address your response…
Lot information: not specified in this record.